Details for New Drug Application (NDA): 218674
✉ Email this page to a colleague
NDA 218674 describes PROCAINAMIDE HYDROCHLORIDE, which is a drug marketed by Ani Pharms, Ascot, Ivax Sub Teva Pharms, Lannett, Lederle, Roxane, Vangard, Watson Labs, Abraxis Pharm, Caplin, Gland, Hikma, Hospira, Intl Medication, Nexus, Pharmafair, Smith And Nephew, Solopak, Warner Chilcott, West-ward Pharms Int, Inwood Labs, and Sandoz, and is included in sixty NDAs. It is available from eleven suppliers. Additional details are available on the PROCAINAMIDE HYDROCHLORIDE profile page.
The generic ingredient in PROCAINAMIDE HYDROCHLORIDE is procainamide hydrochloride. There are nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the procainamide hydrochloride profile page.
The generic ingredient in PROCAINAMIDE HYDROCHLORIDE is procainamide hydrochloride. There are nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the procainamide hydrochloride profile page.
Summary for 218674
| Tradename: | PROCAINAMIDE HYDROCHLORIDE |
| Applicant: | Caplin |
| Ingredient: | procainamide hydrochloride |
| Patents: | 0 |
Suppliers and Packaging for NDA: 218674
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PROCAINAMIDE HYDROCHLORIDE | procainamide hydrochloride | INJECTABLE;INJECTION | 218674 | ANDA | Caplin Steriles Limited | 65145-155 | 65145-155-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (65145-155-10) / 10 mL in 1 VIAL, MULTI-DOSE (65145-155-01) |
| PROCAINAMIDE HYDROCHLORIDE | procainamide hydrochloride | INJECTABLE;INJECTION | 218674 | ANDA | Caplin Steriles Limited | 65145-156 | 65145-156-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (65145-156-10) / 2 mL in 1 VIAL, MULTI-DOSE (65145-156-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 100MG/ML | ||||
| Approval Date: | Feb 4, 2025 | TE: | AP | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 500MG/ML | ||||
| Approval Date: | Feb 4, 2025 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
